Zynga Inc (NASDAQ:ZNGA)chief executive Don Mattrick’s overhaul of the social gaming company’s management team has continued after it was reported that three more senior members of staff are to depart. Zynga Inc (NASDAQ:ZNGA) net profit margin is -13.20% and weekly performance is -4.94%. On last trading day company shares ended up $3.27. Analysts mean target price for the company is $4.62. Zynga Inc (NASDAQ:ZNGA) distance from 50-day simple moving average (SMA50) is -16.68%.
Facebook Inc (NASDAQ:FB) is soon buying Pryte, a mobile data company which allows smartphone users to download applications with temporary mobile data. Pryte offers a technology that is very interesting. It allows smartphone users download applications on their phones with the use of temporally allowances of mobile data. The service is for the users in developing markets where the mobile Internet cost is high. Facebook Inc (NASDAQ:FB) shares advanced 0.75% in last trading session and ended the day on $63.34. Gross Margin is 78.40% and its return on assets is 11.30%. Facebook Inc (NASDAQ:FB) quarterly performance is -11.50%.
Marvell Technology Group Ltd. (NASDAQ:MRVL) announced adding two new smart digital LED driver integrated circuits (ICs) – 88EM8189 and 88EM8803 – further expanding its end-to-end smart lighting platform into LED lamps and fixtures. Marvell Technology Group Ltd. (NASDAQ:MRVL) shares moved down -0.25% in last trading session and was closed at $16.02, while trading in range of $15.86- $16.09. Marvell Technology Group Ltd. (NASDAQ:MRVL) year to date (YTD) performance is 11.87%.
Apple Inc. (NASDAQ:AAPL) is not ready with HealthKit as yet for health tracking purposes, but with the help of the new TV ad of iPhone it is making a good attempt to make people aware of how its smartphone can be put to the use of tracking their health and taking the required measures accordingly for keeping fit. Apple Inc. (NASDAQ:AAPL) ended the last trading day at $644.82. Company weekly volatility is calculated as 1.88% and price to cash ratio as 13.43. Apple Inc. (NASDAQ:AAPL) showed a positive/negative weekly performance of 3.33%.
Citigroup Inc. downgraded shares of Clovis Oncology (NASDAQ:CLVS) from a buy rating to a neutral rating in a report issued on Tuesday, TheFlyOnTheWall.com reports. They currently have $53.00 target price on the stock, down from their previous target price of $109.00. Clovis Oncology Inc (NASDAQ:CLVS) weekly performance is -21.60%. On last trading day company shares ended up $38.40. Analysts mean target price for the company is $98.63. Clovis Oncology Inc (NASDAQ:CLVS) distance from 50-day simple moving average (SMA50) is -33.47%.